MENU
ENTA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Enanta Pharmaceuticals (ENTA) Earnings Date & Reports

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

ENTA is expected to report earnings to rise 20.00% to -101 cents per share on November 17

Enanta Pharmaceuticals ENTA Stock Earnings Reports
Q3'25
Est.
$-1.02
Q2'25
Missed
by $0.01
Q1'25
Beat
by $0.10
Q4'24
Beat
by $0.22
Q3'24
Missed
by $0.20
The last earnings report on August 11 showed earnings per share of -85 cents, missing the estimate of -83 cents. With 89.38K shares outstanding, the current market capitalization sits at 184.92M.
View a ticker or compare two or three
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ENTA showed earnings on August 11, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of drugs and other pharmaceuticals products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
500 Arsenal Street
Phone
+1 617 607-0800
Employees
145
Web
https://www.enanta.com